Warning letter · FDA Warning Letters

Infusionz, LLC: FDA Warning Letter 629248 (Nov 16, 2022)

Agency action: Nov 16, 2022Record ID: fda_warning_-1b7564e851a76c4d
View official source ↗

What happened

Original notice title

Infusionz, LLC MARCS-CMS 629248, November 16, 2022

From the archived source record

FDA has determined that all strengths, varieties, and various flavors of your CBD gummies, CBD fruit snacks, CBD gum, CBD candy, CBD oil/tinctures, and CBD lollipops products are adulterated under section 402(a)(2)(C)(i) of the FD&C Act [21 U.S.C. 342(a)(2)(C)(i)], because they bear or contain an unsafe food additive. FDA is particularly concerned that some of your products are in forms that are appealing to children. For example, children may be at greater risk for adverse reactions associated with certain drug products due to differences in the ability of children to absorb, metabolize, distribute, or excrete such drug products or their metabolites. You also market other products that consumers may confuse with traditional foods for humans, including your CBD gummies, CBD fruit snacks, CBD gum, CBD candy, and CBD lollipops products; therefore, with these products there is a risk of unintended consumption of the CBD ingredient by consumers. Adulterated Human Foods and 301(ll) According to your product labeling, your CBD gummies, CBD fruit snacks, CBD gum, CBD candy, CBD oil/tinctures, and CBD lollipops products are foods to which CBD has been added. Any food additive that has not been approved for its intended use in food is deemed to be unsafe under section 409(a) of the FD&C Act (21 U.S.C. 348(a)) and causes the food to be adulterated under section 402(a)(2)(C)(i) of the FD&C Act, 21 U.S.C. 342(a)(2)(C)(i). Introduction of an adulterated food into interstate commerce is prohibited under section 301(a) of the FD&C Act, 21 U.S.C. 331(a). Many unanswered questions and data gaps about CBD toxicity exist, and some of the available data raise serious concerns about potential harm from CBD. Our review of publicly available data associated with the one FDA-approved CBD drug, as well as our review of published scientific literature, identified potential for liver injury from CBD and potentially harmful interactions with certain drugs.

What the official notice says to do

Check the original notice for the instructions that apply to the named product, company, and affected lots.

Read the official notice →

Status and source details

Status recorded in the archive
No closeout listed in FDA table
Source checked
Jul 16, 2026
Record revision
49ca544b97c1

This is a dated record. Its current status may have changed since the source was captured. A record applies to its stated scope; it is not a safety rating for every product from a company.

Sources, dates, and coverage →

What is affected

Product
Nutrition Facts; CBD gummies; bear Nutrition Facts labels and/or your website provides “Nutrition Facts” for these products
Company
Infusionz, LLC
Lot / identifier
The source does not specify this field.
Market / distribution
The source does not specify this field.